These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
510 related articles for article (PubMed ID: 9708812)
1. Contribution of hepatic parenchymal and nonparenchymal cells to hepatic fibrogenesis in biliary atresia. Ramm GA; Nair VG; Bridle KR; Shepherd RW; Crawford DH Am J Pathol; 1998 Aug; 153(2):527-35. PubMed ID: 9708812 [TBL] [Abstract][Full Text] [Related]
2. The role of hepatic stellate cells and transforming growth factor-beta(1) in cystic fibrosis liver disease. Lewindon PJ; Pereira TN; Hoskins AC; Bridle KR; Williamson RM; Shepherd RW; Ramm GA Am J Pathol; 2002 May; 160(5):1705-15. PubMed ID: 12000722 [TBL] [Abstract][Full Text] [Related]
3. Expression of collagens type I and IV, osteonectin and transforming growth factor beta-1 (TGFbeta1) in biliary atresia and paucity of intrahepatic bile ducts during infancy. Lamireau T; Le Bail B; Boussarie L; Fabre M; Vergnes P; Bernard O; Gautier F; Bioulac-Sage P; Rosenbaum J J Hepatol; 1999 Aug; 31(2):248-55. PubMed ID: 10453937 [TBL] [Abstract][Full Text] [Related]
4. Adenoviral expression of a transforming growth factor-beta1 antisense mRNA is effective in preventing liver fibrosis in bile-duct ligated rats. Arias M; Sauer-Lehnen S; Treptau J; Janoschek N; Theuerkauf I; Buettner R; Gressner AM; Weiskirchen R BMC Gastroenterol; 2003 Oct; 3():29. PubMed ID: 14565855 [TBL] [Abstract][Full Text] [Related]
5. The slow progression of hepatic fibrosis in intrahepatic cholestasis as compared with extrahepatic biliary atresia. Shirahase I; Ooshima A; Tanaka K; Inamoto T; Yamamoto E; Ozawa K; Yamabe H Eur J Pediatr Surg; 1995 Apr; 5(2):77-81. PubMed ID: 7612587 [TBL] [Abstract][Full Text] [Related]
6. Systemic mediators induce fibrogenic effects in normal liver after partial bile duct ligation. Osawa Y; Seki E; Adachi M; Taura K; Kodama Y; Siegmund SV; Schwabe RF; Brenner DA Liver Int; 2006 Nov; 26(9):1138-47. PubMed ID: 17032415 [TBL] [Abstract][Full Text] [Related]
7. Interleukin-17A plays a pivotal role in cholestatic liver fibrosis in mice. Hara M; Kono H; Furuya S; Hirayama K; Tsuchiya M; Fujii H J Surg Res; 2013 Aug; 183(2):574-82. PubMed ID: 23578751 [TBL] [Abstract][Full Text] [Related]
8. The human Delta-like 1 homologue is implicated in the progression of liver fibrosis in biliary atresia. Huang CC; Chuang JH; Huang LL; Chou MH; Wu CL; Chen CM; Hsieh CS; Lee SY; Chen CL J Pathol; 2004 Feb; 202(2):172-9. PubMed ID: 14743499 [TBL] [Abstract][Full Text] [Related]
9. Identification of transforming growth factors actively transcribed during the progress of liver fibrosis in biliary atresia. Lee SY; Chuang JH; Huang CC; Chou MH; Wu CL; Chen CM; Hsieh CS; Chen CL J Pediatr Surg; 2004 May; 39(5):702-8. PubMed ID: 15137003 [TBL] [Abstract][Full Text] [Related]
10. Selective activation of Toll-like receptor 7 in activated hepatic stellate cells may modulate their profibrogenic phenotype. Chou MH; Huang YH; Lin TM; Du YY; Tsai PC; Hsieh CS; Chuang JH Biochem J; 2012 Oct; 447(1):25-34. PubMed ID: 22765640 [TBL] [Abstract][Full Text] [Related]
12. Adenoviral delivery of an antisense RNA complementary to the 3' coding sequence of transforming growth factor-beta1 inhibits fibrogenic activities of hepatic stellate cells. Arias M; Lahme B; Van de Leur E; Gressner AM; Weiskirchen R Cell Growth Differ; 2002 Jun; 13(6):265-73. PubMed ID: 12114216 [TBL] [Abstract][Full Text] [Related]
13. Effects of selective bile duct ligation on liver parenchyma in young animals: histologic and molecular evaluations. Tannuri AC; Coelho MC; de Oliveira Gonçalves J; Santos MM; Ferraz da Silva LF; Bendit I; Tannuri U J Pediatr Surg; 2012 Mar; 47(3):513-22. PubMed ID: 22424347 [TBL] [Abstract][Full Text] [Related]
14. Expression of fas ligand on bile ductule epithelium in biliary atresia--a poor prognostic factor. Liu C; Chiu JH; Chin T; Wang LS; Li AF; Chow KC; Wei C J Pediatr Surg; 2000 Nov; 35(11):1591-6. PubMed ID: 11083430 [TBL] [Abstract][Full Text] [Related]
15. meso-dihydroguaiaretic acid from Machilus thunbergii down-regulates TGF-beta1 gene expression in activated hepatic stellate cells via inhibition of AP-1 activity. Park EY; Shin SM; Ma CJ; Kim YC; Kim SG Planta Med; 2005 May; 71(5):393-8. PubMed ID: 15931574 [TBL] [Abstract][Full Text] [Related]
16. Expression of osteopontin correlates with portal biliary proliferation and fibrosis in biliary atresia. Whitington PF; Malladi P; Melin-Aldana H; Azzam R; Mack CL; Sahai A Pediatr Res; 2005 Jun; 57(6):837-44. PubMed ID: 15845635 [TBL] [Abstract][Full Text] [Related]
17. In situ expression of fibrogenic growth factors and their receptors in biliary atresia: comparison between early and late stages. Faiz Kabir Uddin Ahmed A; Ohtani H; Nio M; Funaki N; Iwami D; Kumagai S; Sato E; Nagura H; Ohi R J Pathol; 2000 Sep; 192(1):73-80. PubMed ID: 10951403 [TBL] [Abstract][Full Text] [Related]
18. Abnormal activation of OPN inflammation pathway in livers of children with biliary atresia and relationship to hepatic fibrosis. Huang L; Wei MF; Feng JX Eur J Pediatr Surg; 2008 Aug; 18(4):224-9. PubMed ID: 18704890 [TBL] [Abstract][Full Text] [Related]
19. Conditional tetracycline-regulated expression of TGF-beta1 in liver of transgenic mice leads to reversible intermediary fibrosis. Ueberham E; Löw R; Ueberham U; Schönig K; Bujard H; Gebhardt R Hepatology; 2003 May; 37(5):1067-78. PubMed ID: 12717387 [TBL] [Abstract][Full Text] [Related]